NUCELL
Live / Registered — Registered (as of 03 May 2022)
What this means for you
Registered since 03 May 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88179777
- Registration number
- 6719190
- Mark type
- Stylized text
- Filed
- 02 Nov 2018
- Published for opposition
- 22 Oct 2019
- Registered
- 03 May 2022
- Attorney of record
- Stephen L. Baker
Goods and services
- Class 001 — Chemicals: Chemical auxiliaries and raw material directed exclusively to the wholesale market and not for the retail market for use by pharmaceutical tablet and capsule manufacturers as a thickener, dispersant, emulsifier, suspending, film-forming agent, enteric coating, flavoring fixative, tablet binder and filler, film-former, and as a viscosity-increasing agent in pharmaceutical tablets and capsules
Owner
- Nucell Pharma Corp., Medley, FL, US
- Nucell Pharma Corp., Medley, FL, US
- Nucell Pharma Corp., Medley, FL, US
Prosecution history
- 03 May 2022 — REGISTERED-PRINCIPAL REGISTER
- 26 Mar 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Mar 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 02 Mar 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 08 Feb 2022 — USE AMENDMENT FILED
- 02 Mar 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 08 Feb 2022 — TEAS STATEMENT OF USE RECEIVED
- 10 Aug 2021 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 01 Jul 2021 — TTAB RELEASE CASE TO TRADEMARKS
- 01 Jul 2021 — OPPOSITION TERMINATED NO. 999999
- 01 Jul 2021 — OPPOSITION DISMISSED NO. 999999
- 19 Nov 2019 — OPPOSITION INSTITUTED NO. 999999
- 22 Oct 2019 — EXTENSION OF TIME TO OPPOSE RECEIVED
- 22 Oct 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 22 Oct 2019 — PUBLISHED FOR OPPOSITION